[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345324-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345324-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cell-and-nuclear-size-is-associated-with-chromosomal-instability-and-tumorigenicity-in-cancer-cells-that-undergo-whole-genome-doubling","Cell and Nuclear Size Is Associated with Chromosomal Instability and Tumorigenicity in Cancer Cells That Undergo Whole Genome Doubling","","Whole genome doubling (WGD) drives chromosomal instability and poor outcomes in cancer. While genomic effects are well described, this study examines nongenetic changes, focusing on how cell and nuclear volume relate to DNA content in tetraploid (4N) cancer cells. Results show volume does not always scale after WGD, generating distinct size states. Smaller 4N cells display higher fitness and mitotic fidelity, increased tumorigenicity, and worse patient survival in WGD-positive cancers, suggesting size as a prognostic biomarker.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cell-and-nuclear-size-is-associated-with-chromosomal-instability-and-tumorigenicity-in-cancer-cells-that-undergo-whole-genome-doubling/345324/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cell-and-nuclear-size-is-associated-with-chromosomal-instability-and-tumorigenicity-in-cancer-cells-that-undergo-whole-genome-doubling/345324.png","ImageObject",300,407,{"name":42,"@type":43},"Oliver","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is whole genome doubling (WGD) and why does it matter in cancer?","Question",{"text":63,"@type":64},"WGD is a frequent event in cancer evolution associated with chromosomal instability, metastasis, and poor prognosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do cell and nuclear size relate to DNA content after WGD?",{"text":68,"@type":64},"Cell and nuclear volume does not always scale with DNA content after WGD, producing 4N cells that differ in size.",{"name":70,"@type":61,"acceptedAnswer":71},"What clinical relevance do the size findings suggest?",{"text":72,"@type":64},"Smaller 4N cells correlate with enhanced tumorigenicity and poor patient survival, indicating cell size may serve as a prognostic biomarker.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345324,1790910131,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Cell and Nuclear Size Is Associated with Chromosomal Instability and Tumorigenicity in Cancer Cells That Undergo Whole Genome Doubling  \nMathew Bloomfield1, Sydney M. Huth1, Daniella S. McCausland1, Ron Saad2,3, Nazia Bano4,5,  \nTran N. Chau1, Megan L. Sweet1, Nicolaas C. Baudoin1, Andrew McCaffrey1, Kai Fluet1, Eva M. Schmelz5, Uri Ben-David2, and Daniela Cimini1  \nWhole genome doubling (WGD) is a frequent event in cancer evolution associated with chromosomal instability, metastasis, and poor prognosis. Whereas the genomic consequences of WGD are well documented, nongenetic alterations that accompany WGD, such as changes to cell and nuclear size, may also play an important role in tetraploid (4N) cancer cell physiology. In this study, we showed that cell and nuclear volume does not always scale with DNA content after WGD in cancer cells, resulting in 4N cells that differ in size. Small size was associated with enhanced cell fitness, mitotic fidelity, and tumorigenicity in 4N cancer cells and with poor patient survival in WGD-positive human cancers. Overall, these results suggest that cell and nuclear size may contribute to the tumorigenic potential of 4N cancer cells and could be an important prognostic marker inhuman tumors that undergo WGD.  \nSignificance: Cancer cell size varies after whole genome duplication, with smaller cells exhibiting high tumorigenicity and correlating with poor patient survival, demonstrating the clinical relevance and highlighting the biomarker potential of cell size.  \nIntroduction  \nWhole genome doubling (WGD) events have played a prominent role in the evolution of species across the tree of life (1) . In humans and other multicellular organisms, some cell types undergo WGD asa part of normal tissue development, but this often results in permanent exit from the cell cycle (2) . When it emerges as a result of anonprogrammed event, WGD can contribute to aging and disease, such as cancer (2) . WGD is one of the most common genomic alterations in cancer and is associated with drug resistance, metastasis, and poor clinical outcome in several tumor types (3–5) . The genetic redundancy afforded by WGD is thought to attenuate the  \nDepartment of Biological Sciences and Fralin Life Sciences Institute, Virginia Tech, Blacksburg, Virginia. 2Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 3Blavatnik School of Computer Science, Tel Aviv University, Tel Aviv, Israel. 4Translational Biology, Medicine, and Health program, Fralin Biomedical Research Institute, Virginia Tech, Roanoke, Virginia. 5Department of Human Nutrition, Foods, and Exercise, Virginia Tech, Blacksburg, Virginia.  \nS. M. Huth and D.S. McCausland contributed equally to this article. Corresponding Authors: Mathew Bloomfield, Department of Cell and Regenerative Biology, University of Wisconsin, 1111 Highland Ave, Madison, WI  \n2N  \nWGD  \nSize scales with DNA content  \nSize subscales with DNA content  \n4N 4N  \nGood High Low  \nCell fitness and tumorigenicity  \nChromosomal instability Vulnerability to proteotoxic and metabolic stress  \nPatient outcome in breast, lung, and esophageal  \nWGD+ cancers  \nHigh Low Poor  \ndeleterious effects of gene mutations and chromosome missegregation, thereby enabling the propagation of genomic and functional diversity that promotes cancer evolution (6, 7) . This is supported by several lines of evidence showing that WGD leads to the accumulation of aneuploidy (8, 9), or an abnormal chromosome number, and is sufficient to induce tumorigenesis in mice (10) .  \nIn addition to its impact on genome content, WGD also results in several nongenetic changes (11, 12), including an increase in cell and nuclear size (13, 14) . Changes in cell and nuclear size can affect cell physiology by altering intracellular transport distances, cytoskeletal structure, gene expression, mitochondrial function, the  \n53705. E-mail: [mbloomfield@vt.edu](mbloomfield@vt.edu), mblo","cbCaijmuFFluumZI","https://ap.wps.com/l/cbCaijmuFFluumZI","pdf",21543568,17,"English","# Significance\n# Introduction\n## Whole genome doubling in cancer evolution\n## Nongenetic changes after WGD and size effects\n## Study rationale and prior observations","[{\"question\":\"What is whole genome doubling (WGD) and why does it matter in cancer?\",\"answer\":\"WGD is a frequent event in cancer evolution associated with chromosomal instability, metastasis, and poor prognosis.\"},{\"question\":\"How do cell and nuclear size relate to DNA content after WGD?\",\"answer\":\"Cell and nuclear volume does not always scale with DNA content after WGD, producing 4N cells that differ in size.\"},{\"question\":\"What clinical relevance do the size findings suggest?\",\"answer\":\"Smaller 4N cells correlate with enhanced tumorigenicity and poor patient survival, indicating cell size may serve as a prognostic biomarker.\"}]","Cell and Nuclear Size Is Associated with Chromosomal Instability and Tumorigenicity in Cancer Cells That Undergo Whole Genome Doubling | PDF",1790057292,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51cb239b9749f6bfe79cf026501a8b7e.webp",983,1315,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/552a8487cee9ad6a0bfe589c564d61fd.webp",982,1314,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/40be0202e54f856b606ce568d0256d70.webp",981,1312,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dcf18e6936cff4b2d12223736a941d20.webp",980,1311]